mental comorbidities
Recently Published Documents


TOTAL DOCUMENTS

29
(FIVE YEARS 21)

H-INDEX

6
(FIVE YEARS 3)

2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
J. Rodrigues ◽  
F. Franco-Pego ◽  
B. Sousa-Pinto ◽  
J. Bousquet ◽  
K. Raemdonck ◽  
...  

Background: Allergic diseases appear to be associated with mood disorders. However, particularly regarding allergic rhinitis (AR), such association has not been adequately systematically reviewed. Therefore, we conducted a systematic review and meta-analysis to quantify the association between AR and depression and anxiety. Methodology: We performed an electronic search of PubMed, Web of Science and Scopus for observational studies assessing the association between AR and depression and anxiety. Such association was quantified by means of random-effects meta-analysis, with estimation of pooled odds ratio (OR). Sources of heterogeneity were explored by subgroup analysis. Results: We included a total of 24 primary studies, of which 23 assessed depression and 11 assessed anxiety. Of these, 12 studies presented OR from multivariable regression models and were included in our meta-analysis. AR was associated with higher odds of depression and anxiety. Conclusions: AR appears to be associated with high risk of depression and anxiety. While our results point to the importance of mental comorbidities among patients with AR, longitudinal studies are needed adopting uniform definitions and presenting results stratified by AR severity.


Author(s):  
Maria Luca ◽  
Clara Grazia Chisari ◽  
Aurora Zanghì ◽  
Francesco Patti

Multiple sclerosis (MS) is an inflammatory demyelinating disorder characterized by the progressive disruption of the myelin sheath around the nerve fibres. The early initiation of disease-modifying treatments is crucial for preventing disease progression and neurological damage. Unfortunately, a diagnostic delay of several years is not uncommon, particularly in the presence of physical and mental comorbidities. Among psychiatric comorbidities, the role of alcohol misuse is still under debate. In this paper, we discuss a case of early-onset alcohol dependence and its possible role in delaying the initiation of a specific therapy for MS. The differential diagnosis between idiopathic and secondary neurodegenerative disorders is often challenging. When dealing with patients reporting an early-onset substance abuse (likely to present organic damage), clinicians may be prone to formulate a diagnosis of secondary neuropathy, particularly when facing non-specific symptoms. This case report highlights the need for in-depth medical investigations (including imaging) in the presence of neurological signs suggesting a damage of the central nervous system, prompting a differential diagnosis between idiopathic and secondary neurodegenerative conditions. Indeed, a timely diagnosis is crucial for the initiation of specific therapies positively affecting the outcome.


2021 ◽  
Vol 9 (2) ◽  
pp. 107-119
Author(s):  
Romano Deluque Júnior ◽  
Cesar Augusto Marton ◽  
Mariane Moreira Ramiro do Carmo

The present study aims to develop a theoretical discussion essay, to discuss the emotional impacts arising from the current scenario of social distance due to the COVID-19 pandemic. Hence, an attempt is made to investigate the elements present in the aforementioned scenario that may pre-say possible indicators of mental suffering. Given the temporary restriction of freedom, the quarantine state also ends, by suppressing the individual's autonomy, at the same time that it confers on him, a deep feeling of impotence in the face of his condition. Socioeconomic status; access to information technologies and social networks; the availability of medical and hygiene supplies; the capacity of health systems; the individual psychic resources related to resilience; as well as the pre-existence of mental comorbidities are just some of the predictors or risk factors for severe mental suffering due to this quarantine.


2021 ◽  
Vol 10 (5) ◽  
pp. 998
Author(s):  
Irini Gergianaki ◽  
Panagiotis Garantziotis ◽  
Christina Adamichou ◽  
Ioannis Saridakis ◽  
Georgios Spyrou ◽  
...  

Comorbidities and multimorbidity, often complicating the disease course of patients with chronic inflammatory rheumatic diseases, may be influenced by disease-intrinsic and extrinsic determinants including regional and social factors. We analyzed the frequency and co-segregation of self-reported comorbid diseases in a community-based Mediterranean registry of patients (n = 399) with systemic lupus erythematosus (SLE). Predictors for multimorbidity were identified by multivariable logistic regression, strongly-associated pairs of comorbidities by the Cramer’s V-statistic, and comorbidities clusters by hierarchical agglomerative clustering. Among the most prevalent comorbidities were thyroid (45.6%) and metabolic disorders (hypertension: 24.6%, dyslipidemia: 33.3%, obesity: 35.3%), followed by osteoporosis (22.3%), cardiovascular (20.8%), and allergic (20.6%) disorders. Mental comorbidities were also common, particularly depression (26.7%) and generalized anxiety disorder (10.7%). Notably, 51.0% of patients had ≥3 physical and 33.1% had ≥2 mental comorbidities, with a large fraction (n = 86) displaying multimorbidity from both domains. Sociodemographic (education level, marital status) and clinical (disease severity, neurological involvement) were independently associated with physical or mental comorbidity. Patients were grouped into five distinct clusters of variably prevalent comorbid diseases from different organs and domains, which correlated with SLE severity patterns. Conclusively, our results suggest a high multimorbidity burden in patients with SLE at the community, advocating for integrated care to optimize outcomes.


Author(s):  
Thais Campelo Bedê Vale ◽  
José Hícaro Hellano Gonçalves Lima Paiva ◽  
Vitória Nunes Medeiros ◽  
Pedro Ítalo Oliveira Gomes ◽  
Hellen Cryslen Bernardo Bezerra ◽  
...  

Abstract: Introduction: Medical students’ mental health has been a concern to the scientific community, especially as a result of the epidemic of mental comorbidities that have become commonplace among the various social groups in modern society. Objectives: To evaluate the prevalence of Burnout among first- to fourth- year medical students and compare different criteria to define the syndrome. Methods: A total of 511 students from three universities in Brazil answered validated instruments to assess burnout (The Maslach Burnout Inventory) and quality of life (WHOQOL-BREF), and a questionnaire prepared by the authors to assess sociodemographic data Results: There was a prevalence of 31.1% of three-dimensional burnout, 37% of two-dimensional burnout and 44,8% of one-dimensional burnout. There were worse levels of emotional exhaustion among students with two-dimensional burnout, compared to those with only one-dimensional criterion, and worse levels of depersonalization among students with three-dimensional burnout, compared to those with two-dimensional criterion only. The same assessed variables showed correlation with all three criteria. Considering the four domains of quality of life - psychological, physical, environment and social relationships, the psychological and physical domains were the ones that correlated the most to all three aspects of the three-dimensional criteria. Emotional exhaustion was the dimension with the strongest association with three of the four quality of life domains. Conclusions: We question whether the three-dimensional criterion should really be the gold standard to define Burnout.


2020 ◽  
Vol 6 (4) ◽  
pp. 205521732096859
Author(s):  
Greta Bütepage ◽  
Ahmed Esawi ◽  
Kristina Alexanderson ◽  
Emilie Friberg ◽  
Chantelle Murley ◽  
...  

Background Comorbidities are common among people with multiple sclerosis (PwMS); yet, their impact on the cost-of-illness (COI) in MS is unknown. Objective Explore the heterogeneity in COI trajectories among newly diagnosed PwMS in relation to type of comorbidity. Methods A nationwide longitudinal cohort study, using prospectively collected Swedish register data for seven years. The COI/year of 639 PwMS diagnosed in 2006, when aged 25–60, was estimated until 2013. Using healthcare data, PwMS were categorised into six comorbidity groups: ocular; cardiovascular, genitourinary or cancer disease; musculoskeletal; mental; neurological other than MS; and injuries. One group of PwMS without comorbidity was also created. Group-based trajectory modelling was applied, examining different COI trajectories within each comorbidity group. Results Across the seven follow-up years, PwMS with mental comorbidities had the highest COI overall (€36,482). Four COI trajectories were identified within each comorbidity group; the largest trajectory had high healthcare costs and productivity losses (36.3%–59.6% of PwMS, across all comorbidity groups). 59.6% of PwMS with mental comorbidity had high healthcare costs and productivity losses. Conclusion High COI and heterogeneity in COI trajectories could be partly explained by the presence of chronic comorbidities in the year around MS diagnosis, including the presence of mental comorbidity.


2020 ◽  
Vol 19 (1) ◽  
Author(s):  
Aayush Visaria ◽  
David Lo ◽  
Pranay Maniar

Abstract Over the past decade, there have been many studies determining the effect of dietary ω-3 and ω-6 fatty acids intake on cognitive performance; however, they have largely been inconsistent in their conclusions. In this letter, we provide context to the article by Dong et al., titled “Association of dietary ω-3 and ω-6 fatty acids intake with cognitive performance in older adults: National Health and nutrition examination Survey (NHANES) 2011–2014” and provide methodological considerations with regards to covariate measurement and inclusion that can be generalized to future cross-sectional studies. In particular, delineating 1) the type and source of fatty acid, in context of an individual’s overall dietary patterns, 2) sociobehavioral risk factors and physical & mental comorbidities, 3) and daily cognitive activity are important to adequately control for covariates.


Author(s):  
Mihaela Fadgyas Stanculete ◽  
Dan L. Dumitrascu

Irritable bowel syndrome (IBS) is the most frequent and well-studied functional gastrointestinal disorder. Being a condition for which the clinical practitioner trained according to the traditional biomedical paradigm cannot detect any organic or significant biochemical findings, it is frequently managed with reduced interest and referred to a psychiatrist. The psychiatrist’s participation in the management of some IBS patients is critical and may improve the diagnosis of mental comorbidities, which are frequent in IBS, as well as the therapy. Pain is an essential feature of IBS. When pain becomes chronic, there is relevant evidence of functional reorganization of the brain. Many studies have highlighted the importance of psychological factors and personality traits in the modulation of pain expression. There is also substantial evidence that chronic pain is associated with mental disorders and substance abuse. This chapter provides a review of comorbidities in IBS at the crossroad of psychiatry with gastroenterology.


2020 ◽  
Vol 24 (43) ◽  
pp. 1-312
Author(s):  
Hollie Melton ◽  
Nick Meader ◽  
Holly Dale ◽  
Kath Wright ◽  
Julie Jones-Diette ◽  
...  

Background People with a history of complex traumatic events typically experience trauma and stressor disorders and additional mental comorbidities. It is not known if existing evidence-based treatments are effective and acceptable for this group of people. Objective To identify candidate psychological and non-pharmacological treatments for future research. Design Mixed-methods systematic review. Participants Adults aged ≥ 18 years with a history of complex traumatic events. Interventions Psychological interventions versus control or active control; pharmacological interventions versus placebo. Main outcome measures Post-traumatic stress disorder symptoms, common mental health problems and attrition. Data sources Cumulative Index to Nursing and Allied Health Literature (CINAHL) (1937 onwards); Cochrane Central Register of Controlled Trials (CENTRAL) (from inception); EMBASE (1974 to 2017 week 16); International Pharmaceutical Abstracts (1970 onwards); MEDLINE and MEDLINE Epub Ahead of Print and In-Process & Other Non-Indexed Citations (1946 to present); Published International Literature on Traumatic Stress (PILOTS) (1987 onwards); PsycINFO (1806 to April week 2 2017); and Science Citation Index (1900 onwards). Searches were conducted between April and August 2017. Review methods Eligible studies were singly screened and disagreements were resolved at consensus meetings. The risk of bias was assessed using the Cochrane risk-of-bias tool and a bespoke version of a quality appraisal checklist used by the National Institute for Health and Care Excellence. A meta-analysis was conducted across all populations for each intervention category and for population subgroups. Moderators of effectiveness were assessed using metaregression and a component network meta-analysis. A qualitative synthesis was undertaken to summarise the acceptability of interventions with the relevance of findings assessed by the GRADE-CERQual checklist. Results One hundred and four randomised controlled trials and nine non-randomised controlled trials were included. For the qualitative acceptability review, 4324 records were identified and nine studies were included. The population subgroups were veterans, childhood sexual abuse victims, war affected, refugees and domestic violence victims. Psychological interventions were superior to the control post treatment for reducing post-traumatic stress disorder symptoms (standardised mean difference –0.90, 95% confidence interval –1.14 to –0.66; number of trials = 39) and also for associated symptoms of depression, but not anxiety. Trauma-focused therapies were the most effective interventions across all populations for post-traumatic stress disorder and depression. Multicomponent and trauma-focused interventions were effective for negative self-concept. Phase-based approaches were also superior to the control for post-traumatic stress disorder and depression and showed the most benefit for managing emotional dysregulation and interpersonal problems. Only antipsychotic medication was effective for reducing post-traumatic stress disorder symptoms; medications were not effective for mental comorbidities. Eight qualitative studies were included. Interventions were more acceptable if service users could identify benefits and if they were delivered in ways that accommodated their personal and social needs. Limitations Assessments about long-term effectiveness of interventions were not possible. Studies that included outcomes related to comorbid psychiatric states, such as borderline personality disorder, and populations from prisons and humanitarian crises were under-represented. Conclusions Evidence-based psychological interventions are effective and acceptable post treatment for reducing post-traumatic stress disorder symptoms and depression and anxiety in people with complex trauma. These interventions were less effective in veterans and had less of an impact on symptoms associated with complex post-traumatic stress disorder. Future work Definitive trials of phase-based versus non-phase-based interventions with long-term follow-up for post-traumatic stress disorder and associated mental comorbidities. Study registration This study is registered as PROSPERO CRD42017055523. Funding This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 24, No. 43. See the NIHR Journals Library website for further project information.


Sign in / Sign up

Export Citation Format

Share Document